BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

217 related articles for article (PubMed ID: 11293389)

  • 1. The effects of exercise on the pharmacokinetics of drugs.
    Khazaeinia T; Ramsey AA; Tam YK
    J Pharm Pharm Sci; 2000; 3(3):292-302. PubMed ID: 11293389
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pharmacokinetics of beta-adrenoceptor blocking agents: clinical significance of hepatic and/or renal clearance.
    Borchard U
    Clin Physiol Biochem; 1990; 8 Suppl 2():28-34. PubMed ID: 1982759
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pharmacokinetic changes in critical illness.
    Boucher BA; Wood GC; Swanson JM
    Crit Care Clin; 2006 Apr; 22(2):255-71, vi. PubMed ID: 16677999
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Basic pharmacology and pharmacokinetics.
    Rasymas A
    Clin Podiatr Med Surg; 1992 Apr; 9(2):211-21. PubMed ID: 1586899
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of exercise on pharmacokinetics.
    Ylitalo P
    Ann Med; 1991 Aug; 23(3):289-94. PubMed ID: 1930919
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Species similarities and differences in pharmacokinetics.
    Lin JH
    Drug Metab Dispos; 1995 Oct; 23(10):1008-21. PubMed ID: 8654187
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Influence of obesity on drug disposition.
    Blouin RA; Kolpek JH; Mann HJ
    Clin Pharm; 1987 Sep; 6(9):706-14. PubMed ID: 3315402
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [The effect of cardiac insufficiency on pharmacokinetics].
    Cheymol G; Jaillon P
    Arch Mal Coeur Vaiss; 1989 Mar; 82(3):391-7. PubMed ID: 2502096
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Transporters as a determinant of drug clearance and tissue distribution.
    Shitara Y; Horie T; Sugiyama Y
    Eur J Pharm Sci; 2006 Apr; 27(5):425-46. PubMed ID: 16488580
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of maturation on drug disposition in pediatric patients.
    Stewart CF; Hampton EM
    Clin Pharm; 1987 Jul; 6(7):548-64. PubMed ID: 3319364
    [TBL] [Abstract][Full Text] [Related]  

  • 11. NTP technical report on the toxicity studies of 2-Chloronitrobenzene (CAS No. 88-73-3) and 4-Chloronitrobenzene (CAS No. 100-00-5) Administered by Inhalation to F344/N Rats and B6C3F1 Mice.
    Bucher J
    Toxic Rep Ser; 1993 Jul; 33():1-F25. PubMed ID: 12209191
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pharmacokinetic simulation of biowaiver criteria: the effects of gastric emptying, dissolution, absorption and elimination rates.
    Kortejärvi H; Urtti A; Yliperttula M
    Eur J Pharm Sci; 2007 Feb; 30(2):155-66. PubMed ID: 17187967
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Effect of physical exercise on the fate of drugs in the body].
    Lutosławska G; Górski J
    Pol Tyg Lek; 1989 Feb; 44(6):139-41. PubMed ID: 2813167
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Rufinamide: clinical pharmacokinetics and concentration-response relationships in patients with epilepsy.
    Perucca E; Cloyd J; Critchley D; Fuseau E
    Epilepsia; 2008 Jul; 49(7):1123-41. PubMed ID: 18503564
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Age-related changes in pharmacokinetics: predictability and assessment methods.
    Perucca E
    Int Rev Neurobiol; 2007; 81():183-99. PubMed ID: 17433924
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The effects of liver and renal dysfunction on the pharmacokinetics of sedatives and analgesics in the critically ill patient.
    Yogaratnam D; Miller MA; Smith BS
    Crit Care Nurs Clin North Am; 2005 Sep; 17(3):245-50. PubMed ID: 16115532
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A review of the effects of chronic exercise and physical fitness level on resting pharmacokinetics.
    Persky AM; Eddington ND; Derendorf H
    Int J Clin Pharmacol Ther; 2003 Nov; 41(11):504-16. PubMed ID: 14620948
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The influence of circadian rhythms on the kinetics of drugs in humans.
    Baraldo M
    Expert Opin Drug Metab Toxicol; 2008 Feb; 4(2):175-92. PubMed ID: 18248311
    [TBL] [Abstract][Full Text] [Related]  

  • 19. NTP Toxicology and Carcinogenesis Studies of 1-Amino-2,4-Dibromoanthraquinone (CAS No. 81-49-2) in F344/N Rats and B6C3F1 Mice (Feed Studies).
    National Toxicology Program
    Natl Toxicol Program Tech Rep Ser; 1996 Aug; 383():1-370. PubMed ID: 12692653
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prediction of human pharmacokinetics-biliary and intestinal clearance and enterohepatic circulation.
    Fagerholm U
    J Pharm Pharmacol; 2008 May; 60(5):535-42. PubMed ID: 18416932
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.